USA-based rare disease drug developer PTC Therapeutics has signed an exclusive global license and collaboration agreement ...

Donald Trump’s potential re-election may boost biopharma mergers and acquisitions by easing regulatory scrutiny following ...

Shares of Israel-based clinical-stage company Purple Biotech jumped 9.5% to 6.90 shekels after it announced positive final ...

GLP-1 receptor (GLP-1R) products have gained immense popularity in recent years, and four are currently approved in major ...

Everest Medicines’ ulcerative colitis treatment Velsipity undergoes Hong Kong regulatory review following successful Phase ...

Berlin, Germany-based radioisotopes specialist Eckert & Ziegler Radiopharma today announced the successful start of ...

Alligator Bioscience restructures to prioritize its leading pancreatic cancer treatment, reducing workforce by 70% and ...

Australia’s Department of Health and Aged Care has developed a new API (application programming interface) for the efficient ...

Biocon Biologics the biosimilars company and subsidiary of Indian drugmaker Biocon, has announced that the US Food and Drug ...

The world’s hematologists are packing their bags in preparation for a visit to San Diego, California, for the American ...

Among important regulatory news last week, US drugmaker BridgeBio Pharma gained Food and Drug Administration (FDA) approval ...

Belgium’s largest drugmaker UCB on Friday announced the successful closing of the sale, divestment and license of its mature ...